Combined Circulatory and Dietary Interventions for Neuropathy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-85
SponsorLoma Linda University
About this trial
The purpose of this study is to evaluate the effectiveness of three different interventions in improving neuropathy symptoms in individuals aged 35-85 with moderate to severe neuropathy. The study will compare three treatment groups: Intraneural Facilitation® (INF®) therapy alone, INF® therapy combined with Neuro vascular index (NVI) food-guided elimination (NVIf), and NVIf alone. The aim is to determine which treatment results in the greatest improvement in neuropathy symptoms, including quality of life, sensory and pain improvements, and functional outcomes.
Eligibility criteria
Qualifiers
Confirmed diagnosis of peripheral neuropathy in the lower extremities by a physician
Lower Extremity Functional Scale (LEFS) score between 0-60 (indicating moderate to significant difficulty in lower extremity function)
Ability to speak and understand English
Ability to provide appropriate written informed consent
Disqualifiers
Any medical condition suggesting potential decline in function over the next 6 months (e.g., ongoing chemotherapy, radiation therapy, or dialysis)
Active alcohol or drug misuse
End-stage renal failure
Uncontrolled hypertension
Trial design
Treatments tested in this trial
- INF® Therapy
- NVIf
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov